The U.S. Food and Drug Administration approved DECNUPAZ (pivekimab sunirine-pvzy) for treating adult patients with blastic plasmacytoid dendritic cell neoplasm ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

FDA